Unecritinib is a potent EGFR tyrosine kinase inhibitor that inhibits ALK, ROS1, and MET and has anticancer activity. Unecritinib is indicated for use in studies of solid tumors and ALK-positive anaplastic large cell lymphoma.
Molecular Weight:
492.37
Purity:
>98.5%
CAS Number:
[1418026-92-2]
Formula:
C23H24Cl2FN5O2
Target:
EGFR/HER2
* VAT and and shipping costs not included. Errors and price changes excepted